secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0000950170-25-086215
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SLDB stockholders approve doubling authorized shares to 240M and adding 9M shares to equity plan
--------------------------------------------------------------------------------

- Authorized common stock increased from 120M to 240M via Certificate of Amendment filed June 12, 2025.
- Equity plan amended to add 9M shares and modify evergreen provision to 6% annual increase from 2026.
- Class I directors Alexander Cumbo and Sukumar Nagendran re-elected with 95% and 92% of votes cast, respectively.
- PricewaterhouseCoopers ratified as auditor for FY2025 with 68.9M votes for, 18.8K against.
- Say-on-pay advisory vote approved with 57.1M for vs. 5.1M against; 6.6M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000095017025086215/0000950170-25-086215-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000095017025086215/sldb-20250612.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-086215

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer